Hey there, time traveller!
This article was published 22/2/2010 (2289 days ago), so information in it may no longer be current.
Winnipeg's International Centre for Infectious Diseases led the bid to locate the plant in this city. ICID's partnership with Canada's largest biotech company, Cangene, the world's largest vaccine manufacturer, Serum Institute of India, the International AIDS Vaccine Initiative in New York City and universities was said to have been superior. The submission was a massive undertaking - more than a year of hard, expensive work, pulling together the elements of a complicated set of criteria. Four centres were in the competition launched by Prime Minister Stephen Harper in early 2008, following his announcement with billionaire Bill Gates that an $88-million plant would be the key piece to this country's $139-million initiative to find a safe, affordable vaccine for the AIDS virus.
The Harper government has not said how the proposals came up short. Last week, the Public Health Agency of Canada's website noted that the Gates Foundation believes a pilot vaccine plant is no longer needed, as there is capacity within the private pharmaceutical industry. That summary dismissal of the efforts of the four centres is insulting. What has changed so dramatically so quickly in the private drug-production market? Further, the decision wipes out the concept of a public, not-for-profit plant that was to produce vaccine doses in sufficient volume to give promising research a good test, arguably taking greater risk than private business will accept.
The four universities and their partners deserve at least a full explanation from the federal government, and so do all Canadians.